Hindsight is 20/20: What Two Marketers Learned at Launch

Session details:

The most useful launch knowledge never makes it into the case studies. It shows up later, in the patterns you only recognize after you've lived through a few launches and had time to reflect with objectivity.

In this candid conversation, two commercial leaders who have taken rare disease and specialty brands from approval through launch open the books on what they'd do differently. No slides, no victory laps: a working session on the myths the industry still budgets for, the assumptions about physicians and patients that need recalibrating once the real audience shows up, the signals that tell a launch team the truth first, and how strong teams decide when the data can't answer the question.

Attendees will leave with:

• Common assumptions that still shape budgets, and where borrowed mass-market thinking breaks first
• Identification of early signals that reveal whether a launch plan is meeting its actual audience, and the widely watched metrics that take far longer to mean anything
• Where cross-functional alignment matters more than launch teams expect, and what should be in place on day one
• Fresh insights from experienced leaders who share what in hindsight, would have made them even more effective.